| 1Z3K | A: | STRUCTURAL INSIGHT INTO THE BINDING DIVERSITY BETWEEN THE TYR-PHOSPHORYLATED HUMAN EPHRINBS AND NCK2 SH2 DOMAIN |
| 2B3O | A:2-108; A:109-215 | CRYSTAL STRUCTURE OF HUMAN TYROSINE PHOSPHATASE SHP-1 |
| 2CI8 | A: | SH2 DOMAIN OF HUMAN NCK1 ADAPTOR PROTEIN - UNCOMPLEXED |
| 2CIA | A: | HUMAN NCK2 SH2-DOMAIN IN COMPLEX WITH A DECAPHOSPHOPEPTIDE FROM TRANSLOCATED INTIMIN RECEPTOR (TIR) OF EPEC |
| 2DLZ | A: | SOLUTION STRUCTURE OF THE SH2 DOMAIN OF HUMAN PROTEIN VAV-2 |
| 2DM0 | A: | SOLUTION STRUCTURE OF THE SH2 DOMAIN OF HUMAN TYROSINE-PROTEIN KINASE TXK |
| 2ECD | A: | SOLUTION STRUCTURE OF THE HUMAN ABL2 SH2 DOMAIN |
| 2EKX | A: | SOLUTION STRUCTURE OF THE HUMAN BMX SH2 DOMAIN |
| 2GE9 | A: | SOLUTION STRUCTURES OF THE SH2 DOMAIN OF BRUTON'S TYROSINE KINASE |
| 2GSB | A: | SOLUTION STRUCTURE OF THE SECOND SH2 DOMAIN OF HUMAN RAS GTPASE-ACTIVATING PROTEIN 1 |
| 2KK6 | A: | SOLUTION STRUCTURE OF SH2 DOMAIN OF PROTO-ONCOGENE TYROSINE-PROTEIN KINASE FER FROM HOMO SAPIENS, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET HR3461D |
| 2LNX | A: | SOLUTION STRUCTURE OF VAV2 SH2 DOMAIN |
| 2MK2 | A: | SOLUTION NMR STRUCTURE OF N-TERMINAL DOMAIN (SH2 DOMAIN) OF HUMAN INOSITOL POLYPHOSPHATE PHOSPHATASE-LIKE PROTEIN 1 (INPPL1) (FRAGMENT 20-117), NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET HR9134A |
| 2YSX | A: | SOLUTION STRUCTURE OF THE HUMAN SHIP SH2 DOMAIN |
| 3EAZ | A: | CRYSTAL STRUCTURE OF SH2 DOMAIN OF HUMAN CSK (CARBOXYL-TERMINAL SRC KINASE), C122S MUTANT. |
| 3NHN | A:146-246 | CRYSTAL STRUCTURE OF THE SRC-FAMILY KINASE HCK SH3-SH2-LINKER REGULATORY REGION |
| 3PS5 | A:1-108; A:109-215 | CRYSTAL STRUCTURE OF THE FULL-LENGTH HUMAN PROTEIN TYROSINE PHOSPHATASE SHP-1 |
| 3VGO | A:256-339 | CRYSTAL STRUCTURE OF THE N-TERMINAL FRAGMENT OF CBL-B |
| 3VRN | A:234-320 | CRYSTAL STRUCTURE OF THE TYROSINE KINASE BINDING DOMAIN OF CBL-C |
| 3VRQ | A:234-320; B:234-320 | CRYSTAL STRUCTURE OF THE TYROSINE KINASE BINDING DOMAIN OF CBL-C (PL MUTANT) |
| 3VS7 | A:147-249; B:147-249 | CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRAZOLO-PYRIMIDINE INHIBITOR 1-CYCLOPENTYL-3-(1H-PYRROLO[2,3-B]PYRIDIN-5-YL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE |
| 4D8K | A:121-226 | CRYSTAL STRUCTURE OF A SH3-SH2 DOMAINS OF A LYMPHOCYTE-SPECIFIC PROTEIN TYROSINE KINASE (LCK) FROM HOMO SAPIENS AT 2.36 A RESOLUTION |
| 4DGP | A:3-110; A:111-218 | THE WILD-TYPE SRC HOMOLOGY 2 (SH2)-DOMAIN CONTAINING PROTEIN TYROSINE PHOSPHATASE-2 (SHP2) |
| 4DGX | A:3-110; A:111-218 | LEOPARD SYNDROME-ASSOCIATED SHP2/Y279C MUTANT |
| 4GWF | A:2-110; A:111-218; B:3-110; B:111-218 | CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH Y279C MUTATION |
| 4H1O | A:2-110; A:111-218 | CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH D61G MUTATION |
| 4H34 | A:4-110; A:111-218 | CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH Q506P MUTATION |
| 4JE4 | A: | CRYSTAL STRUCTURE OF MONOBODY NSA1/SHP2 N-SH2 DOMAIN COMPLEX |
| 4JEG | A: | CRYSTAL STRUCTURE OF MONOBODY CS1/SHP2 C-SH2 DOMAIN COMPLEX |
| 4LUE | A:147-249; B:147-249 | CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH 7-[TRANS-4-(4-METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4-PHENOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE (RESULTING FROM DISPLACEMENT OF SKF86002) |
)
)